Genzyme Corporation announced today that it was included on both the 2009 Dow Jones Sustainability World Index and North American Index. This marks the fifth consecutive year Genzyme has been named to the Dow Jones Sustainability North American Index and the first year the company has been named to the Dow Jones Sustainability World Index.
Genzyme is one of only three biotechnology companies in the United States to be named to the Dow Jones Sustainability World Index this year. More than 2,500 companies apply to be named to the Dow Jones Sustainability World Index and only 300 companies are selected. According to the survey, Genzyme scored the highest in the World Index for its employee code of conduct. Genzyme also scored particularly well in the following areas: corporate governance, environmental policy and talent acquisition and retention.
“Genzyme’s commitment to sustainable long-term growth and social responsibility is integral to our way of doing business,” said Henri Termeer, CEO of Genzyme. “We are focused first and foremost on patients with unmet medical needs and we work to help developing countries build sustainable healthcare systems while providing access to free drug programs, humanitarian initiatives, education and advocacy. From the design of our facilities to how we run our business, Genzyme is reducing our environmental impact and is engaged in supporting our communities.”